While hybrid imaging is not news to molecular imaging experts, the availability of molecular contrast in radiology can open doors to increased cooperation and, potentially, new standard protocols that provide diagnostic information unachievable using independent imaging modalities. "What we've done with Biograph mCT is taken the best Siemens has to offer in CT and enabled the introduction of 'smart' contrast - molecular contrast, using the most advanced PET technology available," says Bernd Montag, CEO of Siemens Healthcare's Imaging and IT Division.

The ability to provide a high-quality imaging environment for patients that is accommodating, comfortable and reliable plays a key role in the success of a hospital's imaging center. Biograph mCT boasts a large bore, short tunnel, and small footprint for unparalleled patient care and comfort. With the fastest PET acquisition times available¹ and ultra-fast CT scanning, higher patient comfort can be achieved and patient movement is decreased, leading to better image quality. Biograph mCT also offers low dose scanning² in both PET and CT, a very important feature, as more and more concerns are being raised with respect to radiation dose.

Biograph mCT was designed to obtain functional, anatomical and molecular information from one noninvasive diagnostic exam. It is the quintessential definition of efficiency: one team, one room, one machine, and one comfortable patient. It offers the potential of diagnosing disease earlier and more effectively managing disease at reduced costs. "And speaking directly to the bottom line," says Montag, "with Biograph mCT, an institution may only need to purchase one imager instead of two, representing a huge cost savings potential in a time when healthcare budgets are tight." Replacing a two scanner purchase with just one can lead to savings in space, construction costs, operator costs and lifecycle costs.